Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 556

1.

A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.

Voshaar T, Lapidus R, Maleki-Yazdi R, Timmer W, Rubin E, Lowe L, Bateman E.

Respir Med. 2008 Jan;102(1):32-41. Epub 2007 Nov 8.

PMID:
17996436
[PubMed - indexed for MEDLINE]
Free Article
2.

The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.

van Noord JA, Cornelissen PJ, Aumann JL, Platz J, Mueller A, Fogarty C.

Respir Med. 2009 Jan;103(1):22-9. doi: 10.1016/j.rmed.2008.10.002. Epub 2008 Nov 20.

PMID:
19022642
[PubMed - indexed for MEDLINE]
Free Article
3.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
[PubMed - indexed for MEDLINE]
4.

Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.

Brashier B, Dhembare P, Jantikar A, Mahadik P, Gokhale P, Gogtay JA, Salvi SS.

Respir Med. 2007 Dec;101(12):2464-71. Epub 2007 Aug 24.

PMID:
17719763
[PubMed - indexed for MEDLINE]
Free Article
5.

[Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease].

Zheng JP, Kang J, Cai BQ, Zhou X, Cao ZL, Bai CX, Zhong NS.

Zhonghua Jie He He Hu Xi Za Zhi. 2006 Jun;29(6):363-7. Chinese.

PMID:
17045014
[PubMed - indexed for MEDLINE]
6.

Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan.

Hsu JY, Perng RP, Lu JY, Wu CP, Huang MS, Luh KT, Yang PC.

J Formos Med Assoc. 2006 Sep;105(9):708-14.

PMID:
16959618
[PubMed - indexed for MEDLINE]
7.

Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.

Zuwallack R, De Salvo MC, Kaelin T, Bateman ED, Park CS, Abrahams R, Fakih F, Sachs P, Pudi K, Zhao Y, Wood CC; Combivent Respimat Inhaler Study Group.

Respir Med. 2010 Aug;104(8):1179-88. doi: 10.1016/j.rmed.2010.01.017. Epub 2010 Feb 20.

PMID:
20172704
[PubMed - indexed for MEDLINE]
Free Article
8.

Improved delivery of ipratropium bromide/fenoterol from Respimat Soft Mist Inhaler in patients with COPD.

Kilfeather SA, Ponitz HH, Beck E, Schmidt P, Lee A, Bowen I, Hesse Ch.

Respir Med. 2004 May;98(5):387-97.

PMID:
15139567
[PubMed - indexed for MEDLINE]
9.

Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients.

Ichinose M, Fujimoto T, Fukuchi Y.

Respir Med. 2010 Feb;104(2):228-36. doi: 10.1016/j.rmed.2009.11.011. Epub 2009 Dec 6.

PMID:
19969446
[PubMed - indexed for MEDLINE]
Free Article
10.

A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group.

van Noord JA, Bantje TA, Eland ME, Korducki L, Cornelissen PJ.

Thorax. 2000 Apr;55(4):289-94.

PMID:
10722768
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma.

von Berg A, Jeena PM, Soemantri PA, Vertruyen A, Schmidt P, Gerken F, Razzouk H.

Pediatr Pulmonol. 2004 Mar;37(3):264-72.

PMID:
14966821
[PubMed - indexed for MEDLINE]
12.

Improved delivery of ipratropium bromide using Respimat (a new soft mist inhaler) compared with a conventional metered dose inhaler: cumulative dose response study in patients with COPD.

Iacono P, Velicitat P, Guemas E, Leclerc V, Thébault JJ.

Respir Med. 2000 May;94(5):490-5.

PMID:
10868713
[PubMed - indexed for MEDLINE]
13.

A dose-ranging study of tiotropium delivered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.

Caillaud D, Le Merre C, Martinat Y, Aguilaniu B, Pavia D.

Int J Chron Obstruct Pulmon Dis. 2007;2(4):559-65.

PMID:
18268929
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.

Donohue JF, van Noord JA, Bateman ED, Langley SJ, Lee A, Witek TJ Jr, Kesten S, Towse L.

Chest. 2002 Jul;122(1):47-55.

PMID:
12114338
[PubMed - indexed for MEDLINE]
15.

A one-year trial of tiotropium Respimat plus usual therapy in COPD patients.

Bateman ED, Tashkin D, Siafakas N, Dahl R, Towse L, Massey D, Pavia D, Zhong NS.

Respir Med. 2010 Oct;104(10):1460-72. doi: 10.1016/j.rmed.2010.06.004.

PMID:
20620037
[PubMed - indexed for MEDLINE]
Free Article
16.

Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease.

Niewoehner DE, Lapidus R, Cote C, Sharafkhaneh A, Plautz M, Johnson P, Kesten S.

Pulm Pharmacol Ther. 2009 Dec;22(6):587-92. doi: 10.1016/j.pupt.2009.08.006. Epub 2009 Sep 6.

PMID:
19737620
[PubMed - indexed for MEDLINE]
17.

Low incidence of paradoxical bronchoconstriction in asthma and COPD patients during chronic use of Respimat soft mist inhaler.

Hodder R, Pavia D, Dewberry H, Alexander K, Iacono P, Ponitz H, Beck E.

Respir Med. 2005 Sep;99(9):1087-95.

PMID:
15893465
[PubMed - indexed for MEDLINE]
Free Article
18.
19.

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.

Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S.

Thorax. 2003 May;58(5):399-404. Erratum in: Thorax. 2005 Feb;60(2):105.

PMID:
12728159
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial.

Tashkin DP, Rennard SI, Martin P, Ramachandran S, Martin UJ, Silkoff PE, Goldman M.

Drugs. 2008;68(14):1975-2000.

PMID:
18778120
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk